CA2197172A1 - Nouveaux derives alkylamino, ligands selectifs pour les recepteurs sigma2 - Google Patents

Nouveaux derives alkylamino, ligands selectifs pour les recepteurs sigma2

Info

Publication number
CA2197172A1
CA2197172A1 CA002197172A CA2197172A CA2197172A1 CA 2197172 A1 CA2197172 A1 CA 2197172A1 CA 002197172 A CA002197172 A CA 002197172A CA 2197172 A CA2197172 A CA 2197172A CA 2197172 A1 CA2197172 A1 CA 2197172A1
Authority
CA
Canada
Prior art keywords
adamantyl
alkyl
ylmethyl
piperidin
group
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002197172A
Other languages
English (en)
Inventor
Jean-Philippe Rocher
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Mitsubishi Chemical Corp
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2197172A1 publication Critical patent/CA2197172A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D275/00—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings
    • C07D275/04—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings condensed with carbocyclic rings or ring systems
    • C07D275/06—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings condensed with carbocyclic rings or ring systems with hetero atoms directly attached to the ring sulfur atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D221/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
    • C07D221/02—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
    • C07D221/04—Ortho- or peri-condensed ring systems
    • C07D221/06—Ring systems of three rings
    • C07D221/10—Aza-phenanthrenes
    • C07D221/12—Phenanthridines
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D267/00—Heterocyclic compounds containing rings of more than six members having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D267/02—Seven-membered rings
    • C07D267/08—Seven-membered rings having the hetero atoms in positions 1 and 4
    • C07D267/12—Seven-membered rings having the hetero atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
    • C07D267/16—Seven-membered rings having the hetero atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems condensed with two six-membered rings
    • C07D267/20—[b, f]-condensed
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D279/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one sulfur atom as the only ring hetero atoms
    • C07D279/02—1,2-Thiazines; Hydrogenated 1,2-thiazines
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D281/00—Heterocyclic compounds containing rings of more than six members having one nitrogen atom and one sulfur atom as the only ring hetero atoms
    • C07D281/02—Seven-membered rings
    • C07D281/04—Seven-membered rings having the hetero atoms in positions 1 and 4
    • C07D281/08—Seven-membered rings having the hetero atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
    • C07D281/12—Seven-membered rings having the hetero atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems condensed with two six-membered rings
    • C07D281/16—[b, f]-condensed
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

L'invention porte sur de nouveaux dérivés alkylamino de formule (I). Ces composés manifestent une sélectivité élevée et une forte affinité pour le récepteur sigma 2; ils se révèlent ainsi utiles pour le traitement de perturbations du système nerveux central ainsi que d'autres perturbations modulées par ce récepteur.
CA002197172A 1994-08-16 1995-08-10 Nouveaux derives alkylamino, ligands selectifs pour les recepteurs sigma2 Abandoned CA2197172A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB9416571A GB9416571D0 (en) 1994-08-16 1994-08-16 Novel alkylamino derivatives as sigma 2 selective ligands
GB9416571.9 1994-08-16

Publications (1)

Publication Number Publication Date
CA2197172A1 true CA2197172A1 (fr) 1996-02-22

Family

ID=10759952

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002197172A Abandoned CA2197172A1 (fr) 1994-08-16 1995-08-10 Nouveaux derives alkylamino, ligands selectifs pour les recepteurs sigma2

Country Status (7)

Country Link
EP (1) EP0777660A1 (fr)
JP (1) JPH10508826A (fr)
KR (1) KR970705550A (fr)
CN (1) CN1164856A (fr)
CA (1) CA2197172A1 (fr)
GB (1) GB9416571D0 (fr)
WO (1) WO1996005185A1 (fr)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0881220A4 (fr) * 1996-02-15 1999-04-21 Mitsubishi Chem Corp Derives du diarylsultame
ATE291015T1 (de) * 1997-11-05 2005-04-15 Mitsubishi Chem Corp Alkylaminoderivate
CA2415103A1 (fr) * 2000-06-30 2002-01-10 The Regents Of The University Of California Procedes et composes pour moduler la fixation de coactivateurs a des recepteurs nucleaires
PL369076A1 (en) * 2001-12-21 2005-04-18 Taisho Pharmaceutical Co, Ltd. Piperazine derivative
WO2004110389A2 (fr) 2003-06-12 2004-12-23 Agy Therapeutics, Inc. Ligands des recepteurs sigma pour regeneration neuronale et retablissement fonctionnel
US7417040B2 (en) 2004-03-01 2008-08-26 Bristol-Myers Squibb Company Fused tricyclic compounds as inhibitors of 17β-hydroxysteroid dehydrogenase 3
PT2739285T (pt) * 2011-08-02 2019-03-26 Helmholtz Zentrum Muenchen Deutsches Forschungszentrum Gesundheit & Umwelt Gmbh Inibição seletiva da protease malt1 por meio de derivados de fenotiazina
JP2023526515A (ja) 2020-05-20 2023-06-21 ザ ボード オブ トラスティーズ オブ ザ ユニヴァーシティ オブ イリノイ リソソーム蓄積症をヒスタチンペプチドで処置するための方法
IT202100013244A1 (it) 2021-05-21 2022-11-21 Fond Telethon MODULATORI DI PrPC E LORO USI

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL90858A (en) * 1988-07-07 1994-08-26 Rhone Poulenc Sante History (Aza) Naftalensultam, their preparation and preparations containing them
ZA908641B (en) * 1989-10-27 1992-06-24 Du Pont (n-phthalimidoalkyl)piperidines
EP0429341A3 (en) * 1989-11-20 1991-11-13 Rhone-Poulenc Sante Heterocyclic derivatives, their preparation and pharmaceuticals containing them
FR2662696A2 (fr) * 1989-12-13 1991-12-06 Rhone Poulenc Sante Antagonistes de la serotonine, leur preparation et medicaments les contenant.
FR2675801A1 (fr) * 1991-04-24 1992-10-30 Rhone Poulenc Rorer Sa Piperidines, leur preparation et les medicaments les contenant.
PT100639A (pt) * 1991-06-27 1993-09-30 Univ Virginia Commonwealth Metodo para o tratamento terapeutico com compostos que sao ligandos ao receptor sigma e compostos ai utilizados, nomeadamente derivados fenilalquil-amina, aminotetralina,piperazina e piperidina

Also Published As

Publication number Publication date
WO1996005185A1 (fr) 1996-02-22
JPH10508826A (ja) 1998-09-02
GB9416571D0 (en) 1994-10-12
KR970705550A (ko) 1997-10-09
EP0777660A1 (fr) 1997-06-11
CN1164856A (zh) 1997-11-12

Similar Documents

Publication Publication Date Title
Moltzen et al. Bioisosteres of arecoline: 1, 2, 3, 6-tetrahydro-5-pyridyl-substituted and 3-piperidyl-substituted derivatives of tetrazoles and 1, 2, 3-triazoles. Synthesis and muscarinic activity
US20210276966A1 (en) Phenyl-Piperazine Derivatives As Serotonin Reuptake Inhibitors
DE60219521T2 (de) Aryloxyphenyl und arylsulfanylphenylderivate
CA1291135C (fr) Derives de substitution de la benzamide, procede de preparation, et composes pharmaceutiques les contenant
KR840002427B1 (ko) 모르폴린 유도체의 제조방법
FR2501690A1 (fr) Derives heterocycliques du type 1,2,4-triazole, leur preparation et leur application pharmacologique
PL178546B1 (pl) Nowe, zasadniczo czyste optycznie, enancjomery prawoskrętne lub lewoskrętne 1-[(4-chlorofenylo)fenylometylo] piperazyny i sposób ich wytwarzania
US4210648A (en) II-Aminoacyl-5,11-dihydro-6H-pyrido(2,3-B) (1,4)benzodiazepin-6-ones and salts thereof
JPH06510748A (ja) 置換ジベンゾキサアゼピン化合物、その製剤組成物及びその使用法
CA1244016A (fr) Diazepinones condenses, procede de preparation et composes pharmaceutiques les contenant
AU670981B2 (en) Tricyclic condensed heterocyclic compounds, their production and use
SK153298A3 (en) Alkylaminobenzothiazole and -benzoxazole derivatives
CA2197172A1 (fr) Nouveaux derives alkylamino, ligands selectifs pour les recepteurs sigma2
JP2008509962A (ja) ５−ｈｔ７受容体アンタゴニスト
EP0881220A1 (fr) Derives du diarylsultame
EP0726898B1 (fr) Composes de phenylindole
CA1294961C (fr) Aminoalcools, leur preparation et leur utilisation, particulierement comme agents therapeutiques
GB1569251A (en) Pyridobenzodiazepines
US5175158A (en) Condensed diazepinones, processes for preparing them and pharmaceutical compositions containing these compounds
FI83317C (fi) Foerfarande foer framstaellning av farmakologiskt vaerdefulla i 11-staellning substituerade 5,11-dihydro-6h -pyrido/2,3-b//1,4/bensodiazepin-6-oner.
JP2574348B2 (ja) 新規縮合ジアゼピノン、その製造法及びそれを含有する医薬組成物
AU630085B2 (en) 4,5,6,7-tetrahydro isothiazolo (4,5-c) pyridine derivatives
US3317538A (en) 4, 4'-diamino-butyrophenones
HU205752B (en) Process for producing phenothiazine derivatives and pharmaceutical compositions comprising same
AU617814B2 (en) Condensed diazepinones

Legal Events

Date Code Title Description
FZDE Dead